Versant-Venture-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-07
Total Holdings
7
Total Value
60208868
Accession Number
0000950123-25-004223
Form Type
13F-HR
Manager Name
Versant-Venture-Management
Data Enrichment
71% identified
5 identified2 unidentified

Holdings

7 positions • $60.2M total value
Manager:
Search and click to pin securities to the top
Monte Rosa Therapeutics, Inc.
Shares:5.7M
Value:$26.2M
% of Portfolio:43.6% ($26.2M/$60.2M)
CRISPR Therapeutics AG
Shares:498.6K
Value:$17.0M
% of Portfolio:28.2% ($17.0M/$60.2M)
Contineum Therapeutics, Inc.
Shares:918.2K
Value:$6.4M
% of Portfolio:10.6% ($6.4M/$60.2M)
Skye Bioscience, Inc.
Shares:2.0M
Value:$3.2M
% of Portfolio:5.3% ($3.2M/$60.2M)
Repare Therapeutics Inc.
Shares:2.6M
Value:$2.6M
% of Portfolio:4.3% ($2.6M/$60.2M)
87978U207
Shares:3.5M
Value:$2.6M
% of Portfolio:4.3% ($2.6M/$60.2M)
00773U108
Shares:506.8K
Value:$2.2M
% of Portfolio:3.7% ($2.2M/$60.2M)